BPC-157 is studied in preclinical research on tendon and ligament healing, muscle injury models, gastric ulcer protection, intestinal barrier function, and vascular endothelial growth signaling
BPC-157 is a synthetic peptide, but it is designed to work in harmony with the bodys natural processes
Long-term exposure to heat, light, or moisture may reduce peptide stability and should be avoided
Daily dosing applies only to the activation phase in weeks 14
The rationale for combining BPC-157 and TB-500 is based on the premise that the two peptides may act through complementary mechanisms
While CTR with ultrasound guidance is not new, the Sonex Health UltraGuideCTR is a new device first used in a CTR procedure in February 2017